Photoaffinity labeling of protein targets in a complex metazoan: proof-of-concept using a probe for Schistosoma mansoni tubulin
Bobby LuceroiD, Thibault AlleiD, Marianna Bufano, Yuemang Yao, Kurt R. BrundeniD, Andrea BrancaleiD, Carlo BallatoreiD, Karol R. FranciscoiD, Conor R. CaffreyiD
Abstract
Treatment of schistosomiasis, a prevalent neglected tropical disease, relies precariously on a single drug. The discovery and development of alternative anti-schistosomal small molecules most often relies on phenotypic (whole-organism) screening, whereas target- or "protein-first"-based discovery options are hampered by a paucity of genetic interrogation strategies and a complex biology. Here, we demonstrate the application of photoaffinity labeling (PAL) as a chemical biology strategy to probe protein target-ligand interactions in the schistosome. Using a triazolopyrimidine (TPD) probe that binds tubulin, we established a PAL workflow with living Schistosoma mansoni worms. The probe elicited deleterious phenotypic responses consistent with the TPD series and, upon UV light activation, covalently labeled tubulin as identified by proteomics. Specific concentration-dependent engagement of tubulin was confirmed using a photostable competitor TPD. When applied directly to worm lysates, the PAL workflow produced non-specific labeling, suggesting that the conformation of the protein target is important for ligand binding. The successful application of PAL for a metazoan is, to our knowledge, novel, and the platform should prove generally applicable to identifying potential drug targets, and exploring protein-ligand interactions, in schistosomes and other organisms.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoni
D.R. Stephens, Ho Yee Joyce Fung, … James J. Collins·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 29, 2025
- Structure-Activity Relationship and Target Investigation of Thiophen-2-yl-Pyrimidines against Schistosoma species
Karol R. Francisco, Bobby Lucero, … Conor R. Caffrey·bioRxiv·Oct 7, 2025
- Highly accurate protein structure prediction-based virtual docking pipeline accelerating the identification of anti-schistosomal compounds
Wenjun Cheng, Mengjie Gu, … Jipeng Wang·PLoS PathogensPeer-reviewed·Oct 13, 2025
- Large-scale RNAi screening uncovers new therapeutic targets in the human parasite Schistosoma mansoni
J. Wang, C. Paz, … J. Collins·bioRxiv·Feb 5, 2020
- A multi-dimensional, time-lapse, high content screening platform applied to schistosomiasis drug discovery
S. Chen, B. M. Suzuki, … C. R. Caffrey·bioRxiv·Oct 6, 2020
- Development of subunit selective proteasome substrates for Schistosoma species
Zhenze Jiang, Elany Barbosa da Silva, … Anthony John O’Donoghue·bioRxiv·Feb 13, 2024